InvestorsHub Logo
Followers 0
Posts 798
Boards Moderated 0
Alias Born 07/27/2018

Re: None

Monday, 10/15/2018 7:06:43 PM

Monday, October 15, 2018 7:06:43 PM

Post# of 41298
Conversion below .48 would require either more shares be given or Amedica handing money back in the form of this dividend from whatever they acquired in the $15 million deal. What you are suggesting would cut that in half. The quarterly mentioning $2k worth of these dividends is hardly proof of something written out nowhere, related to this round of funding. especially when there where previous rounds of funding that contained these dividends that may have a few shots left of conversion. Granted I`m not poking too deep into this angle to find out for myself.

Fintel is reporting 3 N-Q's suggesting to me there are three organizations holding an underlying security that holds these preferred from this round of funding listed in their N-Q filing. It's only a matter of digging to find out who.

If there was previously purchased preferred with the intention of using it to convert to common to cover this would explain the price action. If .48 is a good price and a buy to Sonny then why not take whats left of retails at .24 which is a better buy. either is an equally valid reason for price action in my opinion. But what do I know?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SINT News